Sponsored Content

Upcoming Expansion

New production plant opened in 2026

The new production facility in Madrid represents a major strategic milestone in the company’s growth, significantly strengthening its manufacturing capacity and expanding its expertise in softgel capsule technologies. The site has been specifically designed to support the increasing demand for high-quality softgel products while enhancing operational efficiency and production flexibility.

A key advantage of the facility is the incorporation of fully segregated areas dedicated to pharmaceutical manufacturing, ensuring the highest standards of quality, compliance, and product integrity. In addition, the plant includes a specialized production area focused on vegetal soft capsules, enabling the company to address growing market demand for plant-based and consumer-preferred alternatives.

Beyond increasing production capabilities, the new site positions the company for international expansion, particularly within the highly regulated U.S. pharmaceutical market. By aligning its infrastructure and manufacturing standards with the requirements of this market, the facility creates new opportunities for business growth, strengthens competitiveness, and reinforces the company’s commitment to innovation, quality, and long-term customer partnerships. The expansion not only increases overall production capacity but also broadens the company’s technological capabilities, allowing it to serve a wider range of customers and products while supporting future growth objectives.